Agilent Technologies said Monday it agreed to acquire Biocare Medical for $950 million in cash to expand its pathology portfolio. Biocare’s antibody, reagent and instrument business complements ...

Agilent Technologies Inc. shares are up during Monday’s premarket session as the company announces the acquisition of Biocare Medical for around $950 million. Biocare Medical has been a prominent ...

SAN FRANCISCO and ROSEMONT, Ill., March 23, 2026 /PRNewswire/ -- Biocare Medical, a global leader in immunohistochemistry (IHC) reagents and diagnostic assay solutions, and Proteintech, a global ...

SAN FRANCISCO and MUNICH, March 18, 2026 /PRNewswire/ -- Biocare Medical, a provider of immunohistochemistry (IHC) and in situ hybridization (ISH) reagents and staining platforms, today announced a ...

Expands Agilent’s pathology portfolio through addition of highly complementary antibody, reagent and instrument business with annual double-digit revenue and profit growth since 2021 Expected to be ...

Agilent Technologies, Inc. (NYSE:A) is one of the 10 Best Diagnostics and Research Stocks to Buy According to Analysts. On March 9, 2026, Agilent Technologies, Inc. (NYSE:A) announced entering into a ...

Agilent Technologies Inc. has agreed to buy Biocare Medical LLC for $950 million in cash in a bid to strengthen its pathology portfolio. The deal adds Biocare’s complementary immunohistochemistry ...

Agilent to acquire Biocare in an all-cash transaction valued at $950 million Transaction follows significant period of growth under Excellere Partners and GHO Capital stewardship, with annual ...

Agilent Technologies Inc. announced it has entered into a definitive agreement to acquire Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and ...

Partnership delivers accessible, cost-effective digital slide scanning solutions compatible with Biocare IHC workflows and supportive of AI-enabled digital QC solutions. SAN FRANCISCO and MUNICH, ...

The collaboration combines antibody discovery, protein engineering, and diagnostic assay expertise to support evolving pathology workflows. SAN FRANCISCO and ROSEMONT, Ill., March 23, 2026 /PRNewswire ...